The clinical evaluation of human granulocyte colony-stimulating factor (G-CSF) in 38 patients treated with chemotherapy for ovarian cancer stage III was investigated among 3 groups. G-CSF was not given in group A (19 courses), was administered from day 5 of chemotherapy in group B (53 courses), and was given when the WBC count decreased to below 2,000/mm3 in group C (29 courses). The time to nadir was significantly shorter in group B compared with groups A and C and revealed 10 days for the WBC count and 11 days for the neutrophil count (p<0.01), with mean nadir values of 2,896/mm3 and 982/mm3 respectively, and so the count of WBC and neutrophil have been kept during the course. The effect of G-CSF was not modified by age, body weight or...
Abstract. Neutropenia is a significant dose-limiting toxicity of cancer chemotherapy, espe-cially in...
Granulocyte-colony stimulating factor (G-CSF) is a glycoprotein, the second CSF, sharing some common...
Febrile neutropenia (FN) is a severe dose-limiting side effect of myelosuppressive chemotherapy in p...
The clinical evaluation of human granulocyte colony-stimulating factor (G-CSF) in 38 patients treate...
After informed consent, 86 patients with advanced cancer undergoing potentially myelosuppressive cyt...
In a placebo-controlled double-blind dose-finding trial, 15 patients with ovarian cancer stage III o...
is a recombinant hwnan granuloI:1 j cyte colony stimulating factor (rhG I I CSF). The use of growt...
It was our intention to verify if increases of granulocyte colony stimulating factor (G-CSF) dose we...
A number of cytokines have been used in the past two decades to reduce the complications of neutrope...
Neutropenia is a significant dose-limiting toxicity of cancer chemotherapy, especially in dose-inten...
In this study, nine patients with non-Hodgkin's lymphoma (n=6) and Hodgkin's disease (n=3) receiving...
Background; Rh GM-CSF is known to stimulate the growth of granulocyte-macrophage pre- cursors and ca...
The aim of this study was to evaluate the effectiveness of recombinant granulocyte colony stimulatin...
The effects of granulocyte colony-stimulating factor (G-CSF) on total dose and dose intensity of sta...
Recombinant human granulocyte colony-stimulating factor (rhG-CSF) was administered at a dose of 1-60...
Abstract. Neutropenia is a significant dose-limiting toxicity of cancer chemotherapy, espe-cially in...
Granulocyte-colony stimulating factor (G-CSF) is a glycoprotein, the second CSF, sharing some common...
Febrile neutropenia (FN) is a severe dose-limiting side effect of myelosuppressive chemotherapy in p...
The clinical evaluation of human granulocyte colony-stimulating factor (G-CSF) in 38 patients treate...
After informed consent, 86 patients with advanced cancer undergoing potentially myelosuppressive cyt...
In a placebo-controlled double-blind dose-finding trial, 15 patients with ovarian cancer stage III o...
is a recombinant hwnan granuloI:1 j cyte colony stimulating factor (rhG I I CSF). The use of growt...
It was our intention to verify if increases of granulocyte colony stimulating factor (G-CSF) dose we...
A number of cytokines have been used in the past two decades to reduce the complications of neutrope...
Neutropenia is a significant dose-limiting toxicity of cancer chemotherapy, especially in dose-inten...
In this study, nine patients with non-Hodgkin's lymphoma (n=6) and Hodgkin's disease (n=3) receiving...
Background; Rh GM-CSF is known to stimulate the growth of granulocyte-macrophage pre- cursors and ca...
The aim of this study was to evaluate the effectiveness of recombinant granulocyte colony stimulatin...
The effects of granulocyte colony-stimulating factor (G-CSF) on total dose and dose intensity of sta...
Recombinant human granulocyte colony-stimulating factor (rhG-CSF) was administered at a dose of 1-60...
Abstract. Neutropenia is a significant dose-limiting toxicity of cancer chemotherapy, espe-cially in...
Granulocyte-colony stimulating factor (G-CSF) is a glycoprotein, the second CSF, sharing some common...
Febrile neutropenia (FN) is a severe dose-limiting side effect of myelosuppressive chemotherapy in p...